REGN three-lens brief
Evidence-based stock research on REGN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $822.48 — 24% above current (28 analysts).
- Analyst mean target $822.48 — 24% above current (28 analysts).
- Earnings scheduled 2026-07-30.
REGN closed at $661.49 (-0.97%) as of 2026-07-10. Market cap: $69.35B. P/E (trailing) 16.2. Price is above the 50-day MA and below the 200-day MA. Positives: analyst mean target $822.48 — 24% above current (28 analysts).. Last quarter: Revenue $3.61B, net income $727.20M, free cash flow $3.27B. Watching for: 2026-07-30 earnings release (19 days out).
Why three lenses on REGN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine REGNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/REGN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath REGN brief"></iframe>